{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:17:14Z","timestamp":1788891434880,"version":"build-2803163510"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/ced.12793","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T06:40:39Z","timestamp":1453531239000},"page":"413-416","source":"Crossref","is-referenced-by-count":29,"title":["Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?"],"prefix":"10.1093","volume":"41","author":[{"given":"F.","family":"Galimberti","sequence":"first","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine; Cleveland OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pathology; Cleveland Clinic; Cleveland OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,23]]},"reference":[{"key":"10.1111\/ced.12793-BIB0001|ced12793-cit-0001","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ced.12793-BIB0002|ced12793-cit-0002","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/ced.12793-BIB0003|ced12793-cit-0003","first-page":"4428","article-title":"Sarcoidal granulomas in the mediastinal lymph nodes after treatment for marginal zone lymphoma of the esophagus: report of a case with review of the concept of the sarcoidosis-lymphoma syndrome","volume":"7","author":"Ishida","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1111\/ced.12793-BIB0004|ced12793-cit-0004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CLML.2010.n.052","article-title":"The sarcoid-lymphoma syndrome","volume":"10","author":"Goswami","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1111\/ced.12793-BIB0005|ced12793-cit-0005","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ced.12793-BIB0006|ced12793-cit-0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncprheum0042","article-title":"B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus","volume":"2","author":"Eisenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1111\/ced.12793-BIB0007|ced12793-cit-0007","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/jid.2009.27","article-title":"rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris","volume":"129","author":"Nagel","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ced.12793-BIB0008|ced12793-cit-0008","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1111\/ced.12793-BIB0009|ced12793-cit-0009","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MCP.0000000000000078","article-title":"Cytotoxic agents in sarcoidosis: which one should we choose?","volume":"20","author":"Vorselaars","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1111\/ced.12793-BIB0010|ced12793-cit-0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1445-5994.2011.02612.x","article-title":"New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication","volume":"42","author":"Tong","year":"2012","journal-title":"Intern Med J"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12793","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12793\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:42:33Z","timestamp":1676385753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/41\/4\/413\/6621777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,23]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12793","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,23]]}}}